CELEBREX AND BEXTRA: A BETTER WAY TO MAKE THESE DRUGS SAFER
May 9, 2005 11:07

Celebrex: Lawyer: Monheit Law: Side Effects: Heart Attack: ________

On February 18, a blue-ribbon FDA Advisory Committee found that COX-2 anti-inflammatory drugs (Celebrex, Bextra) increase the risk of heart attacks and strokes and recommended stronger warnings for these drugs. However, even at their lowest available doses, Celebrex and Bextra are very strong drugs and risks may remain. Research has shown that even lower, safer doses are effective, but these 50% to 75% lower doses are not marketed by the manufacturer. Dr. Cohen's new article describes what you and your doctor should know and what you can do about using Celebrex or Bextra more safely.

Ask Monheit Law, "Do I have a Celebrex Case?"

For more information, contact:
Michael Monheit, Esquire, Monheit Law, PC

Date: Tue, 10 May 2005 15:01:23 -0400
From: CDER MEDWATCH LISTSERV
Subject: FDA MedWatch - MRI-Caused Injuries in Patients with Implanted Neu rological Stimulators

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA notified healthcare professionals that serious injury or death can occur when patients with implanted neurological stimulators undergo MRI procedures. The FDA received several reports of serious injury, including coma and permanent neurological impairment. The mechanism for these adverse events is likely to involve heating of the electrodes at the end of the leadwires, resulting in injury to the surrounding tissue. The public health notification also offered recommendations for preventive actions.

Irish Health News Poll